Cargando…

Association between TCF7L2 Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide

Previous studies showed associations between variants in TCF7L2 gene and the therapeutic response to sulfonylureas. All sulfonylureas stimulate insulin secretion by the closure of ATP-sensitive potassium (K(ATP)) channel. The aim of the present study was to compare TCF7L2 genotype specific effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javorský, Martin, Babjaková, Eva, Klimčáková, Lucia, Schroner, Zbynek, Židzik, Jozef, Štolfová, Mária, Šalagovič, Ján, Tkáč, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590634/ https://www.ncbi.nlm.nih.gov/pubmed/23509454 http://dx.doi.org/10.1155/2013/374858

Ejemplares similares

Variation in KCNQ1 is associated with therapeutic response to sulphonylureas
por: Schroner, Zbynek, et al.
Publicado: (2011)

Association of JAG1 gene polymorphism with systemic blood pressure in patients with obstructive sleep apnea: a prospective cohort study
por: Paraničová, Ivana, et al.
Publicado: (2019)

Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records
por: Polavarapu, Nareen Krishna, et al.
Publicado: (2020)

Fabrication and Characterization of Gliclazide Nanocrystals
por: Ravouru, Nagaraju, et al.
Publicado: (2018)

Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐Analysis
por: Dujic, T, et al.
Publicado: (2017)

Tcf7L2 is essential for neurogenesis in the developing mouse neocortex
por: Chodelkova, Olga, et al.
Publicado: (2018)

Preparation and Crystallographic Analysis of Gliclazide Polymorphs
por: Rajamma, A. J., et al.
Publicado: (2015)

Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin
por: Banik, Sujan, et al.
Publicado: (2018)

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
por: Sampathi, Sunitha, et al.
Publicado: (2022)

Acute Exfoliative Dermatitis/Erythroderma Secondary to Gliclazide
por: Al-Badawi, Saifaldeen, et al.
Publicado: (2023)

Effect of TCF7L2 on the relationship between lifestyle factors and glycemic parameters: a systematic review
por: Hosseinpour-Niazi, Somayeh, et al.
Publicado: (2022)

Serotonin is elevated in risk-genotype carriers of TCF7L2 - rs7903146
por: Leiherer, Andreas, et al.
Publicado: (2019)

Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
por: Vatsavai, Leela Krishna, et al.
Publicado: (2016)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
por: Kura, Raghunandan Reddy, et al.
Publicado: (2018)

Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles
por: Nasr, Mohamed, et al.
Publicado: (2021)

Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells
por: Sliwinska, Agnieszka, et al.
Publicado: (2011)

Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
por: Kristensen, Peter L, et al.
Publicado: (2016)

Brain activities of streptozotocin-induced diabetic Wistar rats treated with gliclazide: Behavioural, biochemical and histomorphology studies
por: Ekong, Moses B., et al.
Publicado: (2022)

Bioequivalence Study of Modified-Release Gliclazide Tablets in Healthy Volunteers
por: Rojanasthien, Noppamas, et al.
Publicado: (2012)

The influence of physical division of tablets on the variability of release kinetics of gliclazide
por: Wójcik-Pastuszka, Dorota, et al.
Publicado: (2018)

Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
por: Vatsavai, Leela Krishna, et al.
Publicado: (2018)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Decreased 25-Hydroxy Vitamin D Level Is Associated with All-Cause Mortality in Patients with Type 2 Diabetes at High Cardiovascular Risk
por: Stančáková Yaluri, Alena, et al.
Publicado: (2023)

Gliclazide: Unmasking of glucose-6-phosphate dehydrogenase deficiency: case report
Publicado: (2021)

TCF7 is not essential for glucose homeostasis in mice
por: Kaur, Kiran Deep, et al.
Publicado: (2021)

lncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma
por: Gao, Xiao, et al.
Publicado: (2017)

No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
por: Mathiesen, David S, et al.
Publicado: (2020)

345 The Role of TCF7L2 in Hepatic Metabolic Zonation
por: Ayala, Iriscilla I., et al.
Publicado: (2023)

Drug–drug Interaction between Pravastatin and Gemfibrozil (Antihyperlipidemic) with Gliclazide (Antidiabetic) in Rats
por: Sultanpur, CM, et al.
Publicado: (2010)

Pharmacokinetics and Pharmacodynamics of Gliclazide from Immediate and Modified Release Formulation Tablets in Rats
por: Resztak, M, et al.
Publicado: (2014)

Mutations in gliclazide‐associated genes may predict poor bladder cancer prognosis
por: Wen, Weiheng, et al.
Publicado: (2019)

Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation
por: Adibkia, Khosro, et al.
Publicado: (2019)

Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model
por: Ðanić, Maja, et al.
Publicado: (2019)

The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function
por: Cordiner, Ruth L M, et al.
Publicado: (2021)

Interaction between Omeprazole and Gliclazide in Relation to CYP2C19 Phenotype
por: Dujic, Tanja, et al.
Publicado: (2021)

Solid–Liquid Equilibrium Behavior and Solvent Effect of Gliclazide in Mono- and Binary Solvents
por: Wang, Zihao, et al.
Publicado: (2022)

Gliclazide in Binary and Ternary Systems Improves Physicochemical Properties, Bioactivity, and Antioxidant Activity
por: Ibrahim, Muhammad, et al.
Publicado: (2022)

Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts
por: Karami, Zahra, et al.
Publicado: (2023)

Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
por: Heller, Simon, et al.
Publicado: (2023)

Tcf7l2/Tcf4 Transcriptional Repressor Function Requires HDAC Activity in the Developing Vertebrate CNS
por: Wang, Hui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5k9b52uo55rh2rndb54vigint9